San Sebastian, Spain

Manuel Martin Lomas



Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manuel Martin Lomas: Innovator in Nanoparticle Technology

Introduction

Manuel Martin Lomas is a notable inventor based in San Sebastian, Spain. He has made significant contributions to the field of nanoparticle technology, particularly in the development of immunogenic structures. His work focuses on the intersection of nanotechnology and medicine, aiming to improve treatment options for various diseases.

Latest Patents

Manuel Martin Lomas holds a patent for "Nanoparticles comprising antigens and adjuvants, and immunogenic structures." This patent involves nanoparticles that include adjuvants and antigens, such as tumor and pathogen antigens. The applications of this technology are vast, including the treatment of cancer and infectious diseases. The patent also covers immunogenic structures based on nanoparticles or antibodies with carbohydrate ligands, which can be used for therapeutic and prophylactic purposes, as well as for the isolation and detection of antibodies directed against carbohydrate structures. He has 1 patent to his name.

Career Highlights

Lomas is currently associated with Midatech Limited, a company that focuses on developing innovative therapies using nanotechnology. His work at Midatech Limited has positioned him as a key player in the field of medical advancements through nanoparticle applications.

Collaborations

Throughout his career, Manuel has collaborated with notable professionals in the field, including Gottfried Himmler and G C Mudde. These collaborations have further enriched his research and development efforts.

Conclusion

Manuel Martin Lomas is a pioneering inventor whose work in nanoparticle technology has the potential to revolutionize treatments for cancer and infectious diseases. His contributions to the field are significant and continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…